{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:17:58Z","timestamp":1781194678515,"version":"3.54.1"},"reference-count":94,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The concept of Stevens\u2013Johnson syndrome (SJS) in children is evolving. This manuscript reviews recent advances with the lens of new terminology namely infection-triggered reactive infectious mucocutaneous eruption and drug-induced epidermal necrolysis, with the objective of integrating this novel terminology practically.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Traditionally considered to exist on a spectrum with toxic epidermal necrolysis, SJS in children is more often caused or triggered by infections instead of medications. Proposed pediatric-specific terminology can be applied to literature to gain further insights into blistering severe cutaneous adverse reactions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Distinguishing infection-triggered from drug-triggered blistering reactions is useful for 3 main reasons: (1) early clinically recognizable different features such as isolated or predominant mucositis, (2) different initial management depending on trigger, (3) avoiding the label of a drug reaction on cases triggered by infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001146","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T02:01:54Z","timestamp":1657850514000},"page":"341-348","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Stevens\u2013Johnson syndrome in children"],"prefix":"10.1097","volume":"34","author":[{"given":"Michele L.","family":"Ramien","sequence":"first","affiliation":[{"name":"Division of Community Pediatrics, Department of Pediatrics, Alberta Children's Hospital"},{"name":"Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/bjd.20063","article-title":"Blistering severe cutaneous adverse reactions in children: proposal for pediatric-focused clinical criteria","volume":"185","author":"Ramien","year":"2021","journal-title":"Brit J Dermatol"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ced.14404","article-title":"Reactive infectious mucocutaneous eruption: mycoplasma pneumoniae-induced rash and mucositis and other parainfectious eruptions","volume":"46","author":"Ramien","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"R4-20250730","first-page":"351","article-title":"Sur un syndrome caract\u00e9ris\u00e9 par une l\u2019inflammation simultan\u00e9e de toutes les muqueuses externes (conjonctivale, nasale, linguale, buccopharyng\u00e9e, anale et balano-pr\u00e9puciale) coexistant avec une \u00e9ruption varicelliforme puis purpurique des quatre membres","volume":"30","author":"Rendu","year":"1916","journal-title":"J Prat"},{"key":"R5-20250730","first-page":"54","article-title":"Sur un syndrome caract\u00e9ris\u00e9 par l\u2019inflammation simultan\u00e9e de toutes les muqueuses externes coexistant avec une \u00e9ruption v\u00e9siculeuse des quatre membres, non douloureuse et non r\u00e9cidivante","volume":"25","author":"Fiessenger","year":"1917","journal-title":"Paris M\u00e9d"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(83)80003-6","article-title":"Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes","volume":"8","author":"Huff","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250730","first-page":"333","article-title":"Herpes oris conjunctivae","volume":"14","author":"Fuchs","year":"1876","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R8-20250730","first-page":"445","article-title":"Erythema multiforme majus (Fuchs syndrome) associated with Mycoplasma pneumoniae infection in two patients","volume":"7","author":"Havliza","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1525-1470.2003.03012.x","article-title":"Stevens-Johnson syndrome: a diagnostic challenge in the absence of skin lesions","volume":"20","author":"Vanfleteren","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"R10-20250730","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1072","article-title":"\u2018Atypical\u2019 Stevens-Johnson syndrome?","volume":"120","author":"Schalock","year":"2007","journal-title":"Pediatrics"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaad.2004.07.044","article-title":"Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction?","volume":"52","author":"Schalock","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaad.2014.06.026","article-title":"Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review","volume":"72","author":"Canavan","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R13-20250730","first-page":"427","article-title":"Mucosal respiratory syndrome","volume":"53","author":"Stanyon","year":"1945","journal-title":"Can Med Assoc J"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/pde.13140","article-title":"Mucositis secondary to Chlamydia pneumoniae infection: expanding the mycoplasma pneumoniae-induced rash and mucositis concept","volume":"34","author":"Mayor-Ibarguren","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bjd.17841","article-title":"British Association of Dermatologists\u2019 guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in children and young people","volume":"181","author":"McPherson","year":"2019","journal-title":"Brit J Dermatol"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.13383","article-title":"Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Antoon","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"811\u2013817.e4","DOI":"10.1016\/j.jaad.2016.12.024","article-title":"Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States","volume":"76","author":"Hsu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice","volume":"5","author":"Peter","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R19-20250730","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bjd.20741","article-title":"A retrospective case series of paediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: evaluation of practice using the British Association of Dermatology's National Guidelines for children and young people","volume":"186","author":"Forsyth","year":"2022","journal-title":"Brit J Dermatol"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamadermatol.2021.0385","article-title":"Reactive infectious mucocutaneous eruption associated with SARS-CoV-2 infection","volume":"157","author":"Holcomb","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/pde.14780","article-title":"Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS-CoV-2 and influenza A","volume":"38","author":"Song","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/jdv.17469","article-title":"Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients","volume":"35","author":"Giraud-Kerleroux","year":"2021","journal-title":"J Eur Acad Dermatol"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jamadermatol.2019.3731","article-title":"Use of etanercept in a series of pediatric patients with stevens-johnson syndrome-toxic epidermal necrolysis spectrum disease","volume":"156","author":"Eliades","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1111\/jdv.16741","article-title":"Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridization","volume":"34","author":"Bitar","year":"2020","journal-title":"J Eur Acad Dermatol"},{"key":"R26-20250730","first-page":"472","article-title":"Two pediatric cases of influenza B-induced rash and mucositis: Stevens-Johnson syndrome or expansion of the Mycoplasma pneumoniae-induced rash with mucositis (MIRM) spectrum?","volume":"32","author":"Goyal","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.vaccine.2019.12.028","article-title":"Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999\u20132017","volume":"38","author":"Su","year":"2020","journal-title":"Vaccine"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/pde.13450","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of chikungunya fever: a case series","volume":"35","author":"Garg","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1093\/jpids\/piw085","article-title":"Characterization of children with recurrent episodes of Stevens Johnson syndrome","volume":"6","author":"Olson","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jdv.12392","article-title":"Mycoplasma pneumoniae-associated mucositis--case report and systematic review of literature","volume":"29","author":"Vujic","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1525-1470.2011.01694.x","article-title":"Mycoplasma pneumoniae-associated mucositis: by any other name is not so sweet","volume":"29","author":"Schalock","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.annder.2012.10.590","article-title":"(Stevens-Johnson syndrome concurrent with primary Epstein-Barr virus infection)","volume":"140","author":"Brunet-Possenti","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MEG.0b013e32832b8e10","article-title":"Stevens-Johnson syndrome and cholestatic hepatitis induced by acute Epstein-Barr virus infection","volume":"23","author":"Maggio","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4081\/dr.2010.e6","article-title":"Stevens-Johnson syndrome\/erythema multiforme major and Chlamydia pneumoniae infection in young patients","volume":"2","author":"Duarte","year":"2010","journal-title":"Dermatol Rep"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1346-8138.2005.tb00836.x","article-title":"Primary varicella infection associated with Stevens-Johnson syndrome in a Turkish child","volume":"32","author":"Bay","year":"2005","journal-title":"J Dermatol"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s15010-001-0003-7","article-title":"Varicella zoster virus infection associated with erythema multiforme in children","volume":"29","author":"Prais","year":"2001","journal-title":"Infection"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00004836-198912000-00020","article-title":"Toxic epidermal necrolysis associated with acute cholestatic viral hepatitis A","volume":"11","author":"Werblowsky-Constantini","year":"1989","journal-title":"J Clin Gastroenterol"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"e15416","DOI":"10.1111\/dth.15416","article-title":"An extremely rare mucocutaneous adverse reaction following COVID-19 vaccination: toxic epidermal necrolysis","volume":"35","author":"Mardani","year":"2022","journal-title":"Dermatol Ther"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/jocd.14756","article-title":"A case of Steven-Johnson syndrome after COVID-19 vaccination","volume":"21","author":"Mansouri","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ced.14784","article-title":"COVID-19 vaccine induced Steven-Johnson syndrome: a case report","volume":"46","author":"Dash","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"823837","DOI":"10.3389\/fmed.2022.823837","article-title":"Patients with suspected severe adverse reactions to COVID-19 vaccination admitted to intensive care unit: a case report","volume":"9","author":"Battaglini","year":"2022","journal-title":"Front Med"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/jdv.17988","article-title":"Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine","volume":"36","author":"Aimo","year":"2022","journal-title":"J Eur Acad Dermatol"},{"key":"R43-20250730","first-page":"e9405","article-title":"Stevens-Johnson syndrome due to influenza vaccination","volume":"12","author":"Tong","year":"2020","journal-title":"Cureus"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen","volume":"17","author":"Waites","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3\u200amonths of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/infdis\/jiaa062","article-title":"Circulating antibody-secreting cell response during Mycoplasma pneumoniae childhood pneumonia","volume":"222","author":"Sauteur","year":"2020","journal-title":"J Infect Dis"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.00023","article-title":"Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis","volume":"7","author":"Narita","year":"2016","journal-title":"Front Microbiol"},{"key":"R49-20250730","first-page":"8354892","article-title":"Serum tumor necrosis factor-\u03b1 and interferon-\u03b3 levels in pediatric Mycoplasma pneumoniae pneumonia: a systematic review and meta-analysis","volume":"2018","author":"Wang","year":"2018","journal-title":"Can Respir J"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamadermatol.2019.3602","article-title":"Frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia","volume":"156","author":"Sauteur","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1542\/peds.2015-0278","article-title":"Outbreak of Mycoplasma pneumoniae-associated Stevens-Johnson syndrome","volume":"136","author":"Olson","year":"2015","journal-title":"Pediatrics"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1346-8138.2012.01532.x","article-title":"Distinguishing between erythema multiforme major and Stevens-Johnson syndrome\/toxic epidermal necrolysis immunopathologically","volume":"39","author":"Iwai","year":"2012","journal-title":"J Dermatol"},{"key":"R53-20250730","first-page":"55","article-title":"Mycoplasma pneumoniae-associated Stevens-Johnson syndrome exhibits lymphopenia and redistribution of CD4+ T cells","volume":"102","author":"Wang","year":"2003","journal-title":"J Formos Medical Assoc"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/jpids\/piaa028","article-title":"Rash and mucositis associated with Mycoplasma pneumoniae and Chlamydophila pneumoniae: a recurrence of MIRM?","volume":"10","author":"Brazel","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/pde.14472","article-title":"Clinical features of recurrent Mycoplasma pneumoniae-induced rash and mucositis","volume":"38","author":"Liakos","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/pde.14142","article-title":"Recurrent reactive infectious mucocutaneous eruption (RIME): Insights from a child with three episodes","volume":"37","author":"Mazori","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"8163588","DOI":"10.1155\/2022\/8163588","article-title":"Clinical and epidemiological features of patients with drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Iran: different points of children from adults","volume":"2022","author":"Abtahi-Naeini","year":"2022","journal-title":"Int J Pediatrics"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/pde.14598","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center","volume":"38","author":"Gleghorn","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/pde.14118","article-title":"Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution","volume":"37","author":"Sibbald","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R60-20250730","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4168\/aair.2019.11.2.241","article-title":"Severe cutaneous adverse reactions in Korean pediatric patients: a study from the Korea SCAR Registry","volume":"11","author":"Oh","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaip.2017.02.013","article-title":"Severe cutaneous adverse drug reactions in pediatric patients: a multicenter study","volume":"5","author":"Misirlioglu","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R62-20250730","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/BCR.0000000000000208","article-title":"A 15-year review of pediatric toxic epidermal necrolysis","volume":"36","author":"Quirke","year":"2015","journal-title":"J Burn Care Res"},{"key":"R63-20250730","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/INF.0000000000001571","article-title":"Fever in Stevens-Johnson Syndrome and toxic epidermal necrolysis in pediatric cases: laboratory work-up and antibiotic therapy","volume":"36","author":"Paulmann","year":"2017","journal-title":"Pediatr Infecti Dis J"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/jamadermatol.2019.3589","article-title":"mucocutaneous eruptions in acutely ill pediatric patients-think of Mycoplasma pneumoniae (and other infections) first","volume":"156","author":"Ramien","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/pde.13778","article-title":"Pediatric toxic epidermal necrolysis treated successfully with infliximab","volume":"36","author":"Chafranska","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1097\/INF.0000000000001881","article-title":"Mycoplasma-induced rash and mucositis in a father and son: a case report","volume":"37","author":"Song","year":"2018","journal-title":"Pediatric Infect Dis J"},{"key":"R67-20250730","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/pde.13172","article-title":"Score of toxic epidermal necrosis predicts the outcomes of pediatric epidermal necrolysis","volume":"34","author":"Sorrell","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R68-20250730","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1111\/jdv.16952","article-title":"Duck-like lips: a new clinical feature for diagnosis of Mycoplasma-Induced Rash and Mucositis","volume":"35","author":"Dondi","year":"2021","journal-title":"J Eur Acad Dermatol"},{"key":"R69-20250730","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ajo.2019.07.006","article-title":"Long-term effect of a treatment protocol for acute ocular involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"208","author":"Shanbhag","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R70-20250730","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/ICO.0000000000001985","article-title":"Ophthalmic manifestations of Mycoplasma-induced rash and mucositis","volume":"38","author":"Shah","year":"2019","journal-title":"Cornea"},{"key":"R71-20250730","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaapos.2020.04.006","article-title":"Ocular manifestations of mycoplasma-induced rash and mucositis","volume":"24","author":"Jin","year":"2020","journal-title":"J AAPOS"},{"key":"R72-20250730","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis \u2013 a comprehensive review and guide to therapy. II. Ophthalmic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocular Surf"},{"key":"R73-20250730","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R74-20250730","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.iac.2004.03.012","article-title":"Immune mechanism of drug hypersensitivity","volume":"24","author":"Pichler","year":"2004","journal-title":"Immunol Allergy Clin N Am"},{"key":"R75-20250730","first-page":"1049","article-title":"Recommendations for prevention of drug re-exposure in toxic epidermal necrolysis","volume":"18","author":"O\u2019Brien","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"R76-20250730","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/BCR.0000000000000204","article-title":"Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough","volume":"36","author":"Beck","year":"2015","journal-title":"J Burn Care Res"},{"key":"R77-20250730","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaip.2021.09.014","article-title":"Deep neural network for early image diagnosis of stevens-johnson syndrome\/toxic epidermal necrolysis","volume":"10","author":"Fujimoto","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R78-20250730","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/bjd.19893","article-title":"Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus","volume":"185","author":"Br\u00fcggen","year":"2021","journal-title":"Br J Dermatol"},{"key":"R79-20250730","doi-asserted-by":"crossref","first-page":"113062","DOI":"10.1016\/j.jim.2021.113062","article-title":"ELISpot assay as a diagnostic tool in drug hypersensitivity reactions","volume":"495","author":"Porebski","year":"2021","journal-title":"J Immunol Methods"},{"key":"R80-20250730","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/cea.13861","article-title":"Mycoplasma pneumoniae-associated mucocutaneous disease in children: a case series with allergy workup in a tertiary-care paediatric hospital","volume":"51","author":"Liccioli","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"R81-20250730","first-page":"CD013130","article-title":"Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS\/TEN overlap syndrome","volume":"3","author":"Jacobsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R82-20250730","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaip.2018.05.024","article-title":"A retrospective cohort study of the management and outcomes of children hospitalized with Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"7","author":"Antoon","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R83-20250730","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","article-title":"Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"153","author":"Zimmermann","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R84-20250730","first-page":"e121","article-title":"A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"18","author":"Pozzo-Magana","year":"2011","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"R85-20250730","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","article-title":"Severe cutaneous adverse reactions: emergency approach to nonburn epidermolytic syndromes","volume":"36","author":"Struck","year":"2010","journal-title":"Intensive Care Med"},{"key":"R86-20250730","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jamadermatol.2020.5166","article-title":"Evaluation of etanercept for treatment of reactive infectious mucocutaneous eruption","volume":"157","author":"Miller","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R87-20250730","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/1203475419874444","article-title":"Treatment of Mycoplasma pneumoniae-induced rash and mucositis with cyclosporine","volume":"23","author":"Li","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"R88-20250730","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/pde.13236","article-title":"Successful use of cyclosporin A for Stevens-Johnson syndrome and toxic epidermal necrolysis in three children","volume":"34","author":"John","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R89-20250730","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaad.2020.12.080","article-title":"Biologic treatment in pediatric Stevens-Johnson Syndrome\/toxic epidermal necrolysis: a systematic review","volume":"85","author":"Sachdeva","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R90-20250730","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajo.2020.06.010","article-title":"Mycoplasma Pneumoniae-induced rash and mucositis: a longitudinal perspective and proposed management criteria","volume":"219","author":"Gise","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R91-20250730","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.ophtha.2016.04.041","article-title":"New grading system and treatment guidelines for the acute ocular manifestations of Stevens-Johnson syndrome","volume":"123","author":"Gregory","year":"2016","journal-title":"Ophthalmology"},{"key":"R92-20250730","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/bjd.18387","article-title":"Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients","volume":"182","author":"Ingen-Housz-Oro","year":"2020","journal-title":"Br J Dermatol"},{"key":"R93-20250730","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"key":"R94-20250730","doi-asserted-by":"crossref","first-page":"6431694","DOI":"10.1155\/2018\/6431694","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:12:43Z","timestamp":1753899163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001146","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}